St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its board of directors declared a 7 percent increase in the company’s quarterly dividend to $0.31 per common share. The dividend is payable April 29, 2016, to shareholders of record on March 31, 2016. At the new rate, the annual dividend would be $1.24 per share, compared to the previous annual dividend of $1.16 per share.
About St. Jude Medical
St. Jude Medical is a leading global medical device manufacturer and is dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The Company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management, and cardiovascular diseases. For more information, please visit sjm.com or follow us on Twitter @StJudeMedicalIR.
Forward-Looking Statements
This news release contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 that involve risks and uncertainties. Such
forward-looking statements include the expectations, plans and prospects
for the Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made by
the Company are based upon management’s current expectations and are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements. These risks and uncertainties include market conditions and
other factors beyond the Company’s control and the risk factors and
other cautionary statements described in the Company’s filings with the
SEC, including those described in the Risk Factors and Cautionary
Statements sections of the Company’s Annual Report on Form 10-K for the
fiscal year ended January 3, 2015 and Quarterly Report on Form 10-Q for
the fiscal quarter ended October 3, 2015. The Company does not intend to
update these statements and undertakes no duty to any person to provide
any such update under any circumstance.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160219005860/en/
Contacts:
J.C. Weigelt, 651-756-4347
Investor
Relations
jweigelt@sjm.com
or
Candace
Steele Flippin, 651-756-3029
Media Relations
csflippin@sjm.com